Redefining Every Stage of Investment (RESI) Seed to Exit

讲师： Geoff Fatzinger, Vice President, Regulatory Strategy, Certara

Promising science alone does not create an investable biotechnology company. Investors also need to see a credible path from candidate selection to clinical evidence, regulatory acceptance, value creation, and ultimately a successful partnership or exit. In this practical session, Certara expert, Geoff Fatzinger, will examine five common development gaps that weaken investor confidence: an unclear value proposition, insufficient translational evidence, an untested regulatory path, poorly justified dose and endpoint decisions, and financing milestones that are disconnected from the development plan. Using real-world development perspectives, the speakers will show how integrated scientific, regulatory, and model-informed planning can expose these risks earlier and turn a compelling scientific story into an executable, investor-ready program. Attendees will leave with five questions their teams should be able to answer before their next investor or partnering meeting.